This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

Text Version  RSS  Subscribe  Unsubscribe  Archive  Media Kit February 27, 2015
Home    About AST    Education    Meetings & Events    Public Policy    Contact Us  



Become a Fellow of the AST
The AST Board is pleased to introduce a new designation to recognize those members of AST who have demonstrated a superior commitment to both AST and the field of transplantation: “Fellow of the American Society of Transplantation.” Members who earn fellowship status will be permitted to append the "FAST" designation to their signatures as a public expression of their professional achievement.

Anyone who has been an AST member for at least five years may apply for this fellowship: see the AST website for details on how to apply.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Take part in AST's Pay it Forward Campaign and enter to win an iPad or AST Bucks!
The greatest compliment we can receive is a new member referral, so we want to recognize those of you who consistently enhance our society by recruiting new members.

For each new member that you recruit, your name will be entered to win one of three prizes. Additionally, you’ll receive recognition for your efforts at the 2015 American Transplant Congress, on the AST website, and in the AST eNews. Encourage your colleagues to complete a membership application by April 15, 2015 so that they can register for the ATC at the member discounted registration rate. For further details please visit:

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Increased Measles Activity and Solid Organ Transplantation
In light of the recent increase in measles activity, AST's Infectious Disease COP Executive Committee has drafted a guidance document addressing measles and solid organ transplantation. This information can be found on the AST website: We hope you find this information helpful and encourage you to share it with any colleagues who have questions on this topic.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

  UCLA Immunogenetics Center

The UCLA Immunogenetics Center (UIC) provides comprehensive testing for organ and tissue transplantation. Transplant testing has a long history at UCLA. HLA typing was pioneered here in the 1960's. The development of the microcytoxicity test in 1964 marked the beginning of international testing and standardization of HLA typing. The UCLA Immunogenetics Center has retained its leadership position in HLA research, and in the development of accompanying diagnostic testing. MORE


Mark your calendar! AST Town Hall and Excellence in Transplantation Reception at ATC
We invite you and all AST members to attend the AST Town Hall meeting at ATC on Monday, May 4 at 5:45 p.m. This meeting provides a forum for open discussion between AST membership and leadership about key issues impacting our society and field of transplantation. In addition, we'll announce the Board of Directors election results, honor AST volunteer leaders, and award the 2015 research grants. Immediately following the Town Hall meeting, join friends and colleagues for the Excellence in Transplantation Reception.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Raptor's mission is to develop and commercialize life-altering therapeutics that treat rare, debilitating, and often fatal diseases.
Advertise here!

To find out how to feature your company in the AST eNewsletter and other advertising opportunities, Contact Tom Crist at 972-402-7724.


Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry
American Journal of Transplantation
This study was a retrospective analysis of the European Liver Transplant Registry performed to compare long-term outcomes with prolonged-release tacrolimus versus tacrolimus BD in liver transplantation (January 2008–December 2012). Clinical efficacy measures included univariate and multivariate analyses of risk factors influencing graft and patient survival at 3 years posttransplant. Efficacy measures were repeated using propensity score-matching for baseline demographics. Patients with more than one month of follow-up were excluded from the analyses.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients
Transplant Infectious Disease
Voriconazole is a commonly used antifungal medication in allogeneic hematopoietic stem cell transplantation (allo-HSCT) patients. In solid organ transplantation, voriconazole use has been associated with the development of squamous cell carcinoma (SCC). We sought to determine if voriconazole use was associated with SCC in patients undergoing allo- HSCT.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Outcomes after heart transplantation for amyloid cardiomyopathy in the modern era
American Journal of Transplantation
We conducted a review of patients undergoing heart transplantation (HT) at our institution for amyloid cardiomyopathy (ACM) between 2008 and 2013. Complete follow-up was available for all patients. Nineteen patients with ACM underwent HT during the study period, accounting for 9.4% of all HT performed at our institution during this period. Amyloid subtype was light chain (AL) in 9 patients and transthyretin (ATTR) in 10 (2 wild-type, 7 familial, 1 unknown).
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Transplantation of ABO A2 kidneys into O recipients: Do IgM anti-A1 titers matter?
Clinical Transportation
The ABO blood subgroup A2 expresses lower levels of A antigen on the cell surface and is less immunogenic toward anti-A immunoglobulin present in blood type O or B recipients. Previous studies have shown successful kidney transplantation from A2 donors into O or B recipients with low pre-transplant anti-A titers.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Early changes in liver distribution following implementation of Share 35
American Journal of Transplantation
n June 2013, a change to the liver waitlist priority algorithm was implemented. Under Share 35, regional candidates with MELD greater than 35 receive higher priority than local candidates with MELD less than 35. We compared liver distribution and mortality in the first 12 months of Share 35 to an equivalent time period before.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Missed last week's issue? See which articles your colleagues read most.

    National decline in donor heart utilization with regional variability: 1995–2010 (American Journal of Transplantation)
Survival benefit of solid-organ transplant in the United States (JAMA Surgery)
Become a Fellow of the AST
Prevalence of BK polyomavirus infection and association with renal dysfunction in pediatric heart transplant recipients (The Journal of Heart and Lung Transplantation)

Don't be left behind. Click here to see what else you missed.

AST eNews

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Julie Bernhard, Executive Editor, 469.420.2647  
Contribute news

This edition of the AST eNews was sent to ##Email##. To unsubscribe, click here.

Recent issues
Feb. 20, 2015
Feb. 13, 2015
Feb. 6, 2015
Jan. 30, 2015


7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063